Resource Utilization and Perceptions of Major Molecular Response In Chronic Myeloid Leukemia (CML): Results of a Delphi Panel Study (original) (raw)

Blood

Abstract

4479 Background: With the introduction of tyrosine kinase inhibitors (TKIs), CML treatment and monitoring have undergone significant advances over the last decade. With prolonged survival, it is important to better understand factors that impact therapeutic decisions, particularly when a change in treatment is warranted, and to better understand healthcare resource utilization. Methods: A modified Delphi panel study was conducted, utilizing initial in-depth interviews with 16 CML treating physicians to develop key themes and questions for testing, followed by an on-line survey to capture initial estimates regarding treatment patterns, monitoring and healthcare use. The results were presented and discussed at a live meeting to develop consensus on the estimates provided and complete a second round of surveying. A panel of 7 CML treating physicians, based on their CML treatment experience and pre-established Delphi panel guidelines, from across U.S. was convened. The range and certain...

Michael Flamm hasn't uploaded this paper.

Let Michael know you want this paper to be uploaded.

Ask for this paper to be uploaded.